HS
TPTX

HighVista Strategies’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

HighVista Strategies’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,384
Closed -$2.96M – 128
2022
Q2 		$2.96M Buy
39,384
+18,347
+87% +$815K 1.79% 16
2022
Q1 		$565K Buy
+21,037
New +$707K 0.36% 69

HighVista Strategies's TPTX Position: Q3 2022 in Review

HighVista Strategies sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 39,384 shares — an estimated $2.96M sold.

HighVista Strategies first reported a position in TPTX in Q1 2022 and held it in 2 quarters. The position peaked at $2.96M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • HighVista Strategies reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HighVista Strategies sold 39,384 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.96M.
  • HighVista Strategies first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • HighVista Strategies's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.96M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on HighVista Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.